Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Intangibles: 2017-2025

Historic Intangibles for Autolus Therapeutics (AUTL) over the last 4 years, with Sep 2025 value amounting to $20.3 million.

  • Autolus Therapeutics' Intangibles was N/A to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Intangibles is $20.3 million, which was up 56.83% from $12.9 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Intangibles ranged from a high of $20.3 million in Q3 2025 and a low of $8,000 during Q3 2022.
  • For the 2-year period, Autolus Therapeutics' Intangibles averaged around $14.5 million, with its median value being $12.7 million (2025).
  • Data for Autolus Therapeutics' Intangibles shows a maximum YoY plummeted of 90.80% (in 2022) over the last 5 years.
  • Over the past 4 years, Autolus Therapeutics' Intangibles (Quarterly) stood at $65,000 in 2021, then crashed by 90.80% to $8,000 in 2022, then reached $12.4 million in 2024, then reached $20.3 million in 2025.
  • Its Intangibles was $20.3 million in Q3 2025, compared to $12.9 million in Q2 2025 and $12.5 million in Q1 2025.